Fennec Pharmaceuticals Inc (FENC)
9.24
-0.14
(-1.49%)
USD |
NASDAQ |
Apr 23, 16:00
9.235
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Gross Profit Margin (Quarterly): 92.96% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 92.96% |
| September 30, 2023 | 94.92% |
| June 30, 2023 | 95.55% |
| Date | Value |
|---|---|
| March 31, 2023 | 94.34% |
| December 31, 2022 | 94.40% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
92.96%
Minimum
Dec 2023
95.55%
Maximum
Jun 2023
94.43%
Average
94.40%
Median
Dec 2022
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 46.92% |
| OptiNose Inc | 89.27% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -70.32% |
| Return on Invested Capital | -88.93% |
| Profit Margin (Quarterly) | -27.55% |
| Operating Margin (Quarterly) | -19.39% |